Pre-Conference Workshop

How will our patients survive the next drug shortage?

Thursday, October 18th
9:00 am – 12:00 pm
$50 for all attendees

Drug shortages, recalls, or discontinuations of key human generic pharmaceuticals are occurring more and more often; impacting our ability to provide quality care for pets with cancer.   This pre-conference forum will provide insights into the root causes of the short supply issues, address some of the impact on patient care, and an evidence-based review of chemotherapy compounding.  Our speakers will be Dr. Butch Kukanich, Associate Director of Pharmacology, Kansas State University, Dr. Kevin Hahn, EVP of Tri-Source Pharma, and VCS Member panelists.


Presenter #1:  Dr. Butch Kukanich

Topic:  The ins and outs of drug compunding in veterinary medicine

Dr. Kukanich is a Professor of Pharmacology and Assistant Department Head at Kansas State University, College of Veterinary Medicine. He earned his DVM from Virginia Tech in 1997 and his PhD in 2005 from North Carolina State University. Dr. Kukanich earned Diplomate status in the American College of Veterinary Clinical Pharmacology in 2004. He has 7 years clinical experience in emergency medicine and small animal private practice. Dr. Kukanich’s research interests focus on companion animal pharmacology, drug interactions, drug metabolism and analgesia.

 

 

Presenter #2:  Dr. Kevin Hahn

Topic: Drug Shortages in Veterinary Medicine– Causes, Patient Impact, Practical Solutions

Specialty human pharmaceutical injectable products used off-label by veterinarians to manage their companion animal patients are in critical short supply.   Some are all too common and familiar to veterinary oncologists such as doxorubicin and vincristine; and other products to mitigate treatment side effects or improve quality of life.   Reasons for the spike in drug shortages include a lack of materials to make the drugs, rising costs to maintain governmental approval, fewer domestic pharmaceutical companies making drugs, and increased scrutiny of overseas manufacturing quality control processes.   Shortages are pushing the costs of existing drugs ever higher resulting in a rationing or dwindling supply of lesser cost, lesser effective alternative drug products or the use of compounded versions.   This presentation will examine market forces, supply chain management, and regulatory expectations that influence the continuity of drug product availability in the veterinary practice.